Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
2295-31-0
Purity
95%
2,4-Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes mellitus. It is a PPARγ (Peroxisome proliferator-activated receptor, gamma) agonist, IC50 = 0.2 µM. It also inhibits GSK-3 (Glycogen synthase kinase-3 beta), IC50 = 100µM.
Properties
Name
2,4-Thiazolidinedione
Smiles
O=C1CSC(=O)N1
Targets
Please log in to see this information
SDS
1,3-thiazolidine-2,4-dione | 2,4-Thiazolidinedione | 2,4-thiazolidinedion | thiazolidine-2,4-dione | thiazolidinedione | thiazoline-2,4-dione
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
1,3-thiazolidine-2,4-dione | 2,4-Thiazolidinedione | 2,4-thiazolidinedion | thiazolidine-2,4-dione | thiazolidinedione | thiazoline-2,4-dione
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.